AIM IMMUNOTECH INC. Proceeds from Issuance of Warrants
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Issuance of Warrants of $7.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-27
- AIM IMMUNOTECH INC. proceeds from issuance of warrants for the quarter ending 2020-12-31 was $0.00.
- AIM IMMUNOTECH INC. proceeds from issuance of warrants for the quarter ending 2020-09-30 was $0.00.
- AIM IMMUNOTECH INC. proceeds from issuance of warrants for the quarter ending 2020-06-30 was $0.00.
- AIM IMMUNOTECH INC. proceeds from issuance of warrants for the quarter ending 2020-03-31 was $25.77M.
- AIM IMMUNOTECH INC. proceeds from issuance of warrants for fiscal 2025 was $7.31M.
- AIM IMMUNOTECH INC. proceeds from issuance of warrants for fiscal 2020 was $25.77M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.31M 10-K · filed 2026-03-27 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $25.77M 10-K · filed 2021-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $25.77M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $25.77M 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $25.77M 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |